Conmed (CNMD) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding
Federal contractsUSAspending.gov, last 12 months: 9 awardsAwards on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about CNMD filings

Are insiders buying or selling CONMED Corporation (CNMD) stock?

Neither. CONMED Corporation (CNMD) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CNMD recently?

None. No member of Congress disclosed a CNMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CNMD smart-money data?

This summary uses filings available on Oct 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on CNMD

Lean long1 source:
- Funds
Lean short1 source:
- Politicians

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
Lean short1 buy · 2 salesExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
Lean long2 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CNMD filings

Are insiders buying or selling CONMED Corporation (CNMD) stock?

Neither. CONMED Corporation (CNMD) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CNMD recently?

None. No member of Congress disclosed a CNMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CNMD smart-money data?

Funds

What funds are doing

3 moves · 6 mo

Buys/Adds$29.3MSells/Trims$17.3M

Buys/Adds (2)

LA
LSV Asset
Q2 2026 13F
$12.7M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
TS
Two Sigma
Q1 2026 13F
$16.6M
added

Sells/Trims (1)

CI
Citadel
Ken Griffin · Q1 2026 13F
$17.3M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 28, 2026

Earnings came in 3.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 28, 2026

Period ending

Sep 30, 2026

Earnings per share

$1.04+3.74% beat

$1.00 expected

Revenue

$335.6M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 28, 2026	$1.04est. $1.00	+3.74%beat	$335.6MSEC filing	-0.7%from $337.9M
Jun 30, 2026Reported Jul 29, 2026	$1.38est. $1.11	+24.33%beat	$343.5MSEC filing	+0.3%from $342.3M
Mar 31, 2026Reported Apr 29, 2026	$0.89est. $0.82	+8.79%beat	$317.0MYahoo Finance	-1.3%from $321.3M
Dec 31, 2025Reported Jan 28, 2026	$1.43est. $1.32	+8.04%beat	$373.2MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 5, 2025	$1.08est. $1.05	+2.86%beat	$337.9MSEC filing	+6.7%from $316.7M
Jun 30, 2025Reported Jul 30, 2025	$1.15est. $1.12	+2.68%beat	$342.3MSEC filing	+3.1%from $332.1M
Mar 31, 2025Reported Apr 30, 2025	$0.95est. $0.81	+17.28%beat	$321.3MSEC filing	+2.9%from $312.3M
Dec 31, 2024Reported Feb 5, 2025	$1.34est. $1.20	+11.67%beat	$1.31B · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $43.60
52-wk high: $53.66
High: $46.47
52-wk low: $31.44
Low: $43.50
Prev close: $45.76
Mkt cap: $1.37B
P/E: 24.7x
ROE: +5.5%
Fwd P/E: 27.2x
Beta: 0.94
P/S: 1.0x
P/B: 1.4x
Profit margin: +4.1%
Op margin: +14.6%

Fundamentals

Is the business strong?

Reasonably priced and running thin margins.

Net margin: 4.1%
P/E: 24.74
Forward P/E: 27.17
Market cap: $1.4B

Valuation

P/S1.00
P/B1.36

Quality

Operating margin14.6%
ROE5.5%
ROA4.1%

Growth

Beta0.94

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

40 / 100

RSI 14

55balanced

20D volatility

43%annualized

52-week range

$45.72

$31.44$53.66

20D support

$43.50recent floor

20D resistance

$49.73recent ceiling

Returns

5D -7.5%20D -0.5%60D -7.3%

Price vs moving averages

SMA20 -1.4%SMA50 -3.2%SMA200 +10.4%

Volume pace

1.29xvs prior 20D

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding
Federal contractsUSAspending.gov, last 12 months: 9 awardsAwards on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about CNMD filings

Are insiders buying or selling CONMED Corporation (CNMD) stock?

Neither. CONMED Corporation (CNMD) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CNMD recently?

None. No member of Congress disclosed a CNMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CNMD smart-money data?

13F: filed up to 45 days late.

Smart money on CNMD

Lean long1 source:
- Funds
Lean short1 source:
- Politicians

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
Lean short1 buy · 2 salesExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
Lean long2 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CNMD filings

Are insiders buying or selling CONMED Corporation (CNMD) stock?

Neither. CONMED Corporation (CNMD) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CNMD recently?

None. No member of Congress disclosed a CNMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CNMD smart-money data?

Funds

What funds are doing

3 moves · 6 mo

Buys/Adds$29.3MSells/Trims$17.3M

Buys/Adds (2)

LA
LSV Asset
Q2 2026 13F
$12.7M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
TS
Two Sigma
Q1 2026 13F
$16.6M
added

Sells/Trims (1)

CI
Citadel
Ken Griffin · Q1 2026 13F
$17.3M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 28, 2026

Earnings came in 3.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 28, 2026

Period ending

Sep 30, 2026

Earnings per share

$1.04+3.74% beat

$1.00 expected

Revenue

$335.6M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 28, 2026	$1.04est. $1.00	+3.74%beat	$335.6MSEC filing	-0.7%from $337.9M
Jun 30, 2026Reported Jul 29, 2026	$1.38est. $1.11	+24.33%beat	$343.5MSEC filing	+0.3%from $342.3M
Mar 31, 2026Reported Apr 29, 2026	$0.89est. $0.82	+8.79%beat	$317.0MYahoo Finance	-1.3%from $321.3M
Dec 31, 2025Reported Jan 28, 2026	$1.43est. $1.32	+8.04%beat	$373.2MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 5, 2025	$1.08est. $1.05	+2.86%beat	$337.9MSEC filing	+6.7%from $316.7M
Jun 30, 2025Reported Jul 30, 2025	$1.15est. $1.12	+2.68%beat	$342.3MSEC filing	+3.1%from $332.1M
Mar 31, 2025Reported Apr 30, 2025	$0.95est. $0.81	+17.28%beat	$321.3MSEC filing	+2.9%from $312.3M
Dec 31, 2024Reported Feb 5, 2025	$1.34est. $1.20	+11.67%beat	$1.31B · FYSEC filing	No year-ago quarter

Open: $43.60
52-wk high: $53.66
High: $46.47
52-wk low: $31.44
Low: $43.50
Prev close: $45.76
Mkt cap: $1.37B
P/E: 24.7x
ROE: +5.5%
Fwd P/E: 27.2x
Beta: 0.94
P/S: 1.0x
P/B: 1.4x
Profit margin: +4.1%
Op margin: +14.6%

Fundamentals

Is the business strong?

Reasonably priced and running thin margins.

Net margin: 4.1%
P/E: 24.74
Forward P/E: 27.17
Market cap: $1.4B

Valuation

P/S1.00
P/B1.36

Quality

Operating margin14.6%
ROE5.5%
ROA4.1%

Growth

Beta0.94

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

40 / 100

RSI 14

55balanced

20D volatility

43%annualized

52-week range

$45.72

$31.44$53.66

20D support

$43.50recent floor

20D resistance

$49.73recent ceiling

Returns

5D -7.5%20D -0.5%60D -7.3%

Price vs moving averages

SMA20 -1.4%SMA50 -3.2%SMA200 +10.4%

Volume pace

1.29xvs prior 20D

CONMED Corporation

Smart money at a glance

What do analysts expect?

Questions about CNMD filings

Smart money on CNMD

Questions about CNMD filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 3.7% above what analysts expected.

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

CONMED Corporation

Smart money at a glance

What do analysts expect?

Questions about CNMD filings

Smart money on CNMD

Questions about CNMD filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 3.7% above what analysts expected.

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

CONMED Corporation

Overview

Questions about CNMD filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

CONMED Corporation

Overview

Questions about CNMD filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.